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Wednesday, February 29, 2012 613aactivated by N-methyl-d-aspartate. Due to their high Ca2þ permeability and
voltage-dependent channel block by Mg2þ, NMDA receptors play a central
role in development through stabilization of synaptic connections, as well as
in learning and memory by mediating many forms of synaptic plasticity.
The mechanisms by which the ion channel of NMDA receptors selects Ca2þ
for permeation over all other physiological ions, while binding Mg2þ and
restricting its permeation, are not well understood. We hypothesize that the
slightly different radii and electronic properties of Mg2þ and Ca2þ ions result
in drastically different free energy barriers for transition of the ions from
a binding site in the selectivity filter toward the intracellular solution. We
are applying quantitative theoretical ‘‘bottom up’’ approaches to this complex
system by combining methods of computational chemistry, molecular mechan-
ics (MM), and bioinformatics. The structure of the NMDA receptor channel is
constructed and refined using experimental information, homology modeling
and extensive molecular dynamics simulations. We are performing quantum
chemical calculations to determine the energy of the transition state of model
ligand exchange reactions that mimic divalent ion transition from the selectiv-
ity filter of NMDA receptors to water. Quantum calculations are used to
parameterize a polarizable molecular mechanics force field for these divalent
ion interactions with organic ligands with the further goal to perform MM sim-
ulations. Umbrella sampling and thermodynamic integration simulations are
used to compute free energies of transfer of divalent ions between water
and a model of the NMDA ion selectivity filter as well as free energy barriers
for these transitions.
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The ionotropic glutamate receptors (iGluRs), activated by the amino acid
L-glutamate, account for the vast majority of excitatory neurotransmission in
the central nervous system. Given their centrality to the nervous system, it is
not surprising that these receptors have been linked to various neurological
disorders including epilepsy, Alzheimer’s and Parkinson’s disease. Based on
their sequence, pharmacological properties and function, iGluRs are classified
primarily into three subtypes, namely amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA), kainate (KA), and N-methyl-D-aspartate
(NMDA) receptors.
Previously we have reported the identification of a potential ionic switch, or
latch, located within the hinge region of non-NMDA receptors. Here we de-
scribe extensive molecular dynamics simulations to explore the conformational
behaviour of the ionic switch and its influence on the closure or opening of the
ligand-binding domain. The position of the switch appears to directly control
the conformation of the ligand-binding domain. We discuss the results with re-
spect to the general mechanism of how different ligands are able to induce the
same mechanism of domain closure.
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Kainate-type ionotropic glutamate receptors (KARs) assemble primarily as
heteromeric complexes at glutamatergic synapses. In most cases, KAR-
mediated synaptic events exhibit slow and variable deactivation kinetics in
contrast to the fast gating properties typically observed with recombinant
KARs. It is still not clear which factors contribute to the slowing of KAR re-
sponses at synapses, and it remains to be understood the low affinity neuro-
transmitter, L-Glu, triggers prolonged activations of KARs. Here, we
investigated the biophysical and stoichiometric properties of recombinant het-
eromeric KARs assembled from the GluK2 and GluK5 receptor subunits. To
do this, we used a combination of outside-out patch electrophysiology to ex-
amine functionality and a fluorescent subunit counting technique to assess het-
eromerization. As expected, the degree of heteromerization with GluK2/
GluK5 subunits in individual patch recordings showed a positive correlation
with slow deactivation kinetics and responsiveness to the agonist, AMPA. In-
terestingly, preliminary data from subunit counting experiments suggest that
the stoichiometry of heteromeric KARs is fixed. Furthermore, electrophysio-
logical experiments reveal that GluK2/GluK5 heteromers are insensitive to
external anions and cations. Since both anion and cation binding sites line
the interface between KARs subunits, our data suggest that the process ofheteromer assembly affects functionality by disrupting this region of the
mature protein.Platform: Cardiac Muscle
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Familial Hypertrophic Cardiomyopathy (FHC) is an autosomal dominant
disease of the heart. The severity of the disease ranges from mild cases to
sudden cardiac death or progression to heart failure. FHC is mostly caused
by mutations in genes encoding for sarcomeric proteins, 30-40% of the patients
are affected by missense mutations in one allele of the b-myosin heavy chain
(MYH7).
To gain further insights into the mechanisms of FHC-progression in heterozy-
gous patients we performed a comparative expression analysis of the wildtype
and the mutated MYH7 allele. We have analyzed samples from Musculus
soleus and myocardium of genotyped and clinically well-characterized
FHC-patients with different MYH7-mutations. We demonstrated an unequal
allelic mRNA expression for each mutation analysed. The ratios of the mu-
tated mRNA ranged from 29% to 66% in a mutation-specific manner. They
were comparable in myocardium and soleus muscle and, importantly, were es-
sentially the same at the protein level. Intriguingly, we observed a correlation
between life expectancy and fraction of mutated mRNA or protein. Thus, the
allelic imbalance may provide a novel factor underlying the progression of
FHC.
Our results suggest that the allelic imbalance is induced by differential regula-
tion of the mutated MYH7 mRNA-expression. Thus we aimed to identify
molecular mechanisms that may account for the mutation-related different
mRNA levels. Bioinformatical analysis revealed that mutation V606M disrupts
an exonic splicing enhancer site. Additionally, for the mutation R723G severe
changes in the mRNA secondary structure were predicted. Alternative splicing
variants of the V606-allele and a structure-related increased stability of
the R723G-allele thus may provide potential factors inducing altered levels
of mutated MYH7-mRNA.
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Hypertrophic cardiomyopathies (HCM) and dilated cardiomyopathies (DCM)
are common inherited cardiovascular diseases, often resulting from single
point mutations in genes encoding sarcomeric proteins. Genetic and clinical
studies have identified several hundred mutations, including severe disease
causing mutations in b-myosin heavy chain (MHC). Despite the clinical sig-
nificance, few single molecule studies exist for mutated b-cardiac myosin,
primarily due to difficulties of heterologous protein expression and instrumen-
tal limitations. Previous studies have used mouse a-cardiac myosin or biopsies
from patients. Those studies are not optimal to understand the molecular
mechanism of HCM/DCM because there are significant differences between
mouse a- and human b-MHC. Furthermore, biopsy samples from patients
are often inhomogeneous mixtures of wildtype (wt) and mutants. This may
explain why there have been many inconsistencies between the previous
studies.
Here, we demonstrate the first single molecule studies of recombinant human
cardiac myosin. We expressed homogenous and fully functional wt human
cardiac a- and b-S1 with human light chains bound. Then, we characterized
